These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 95009)

  • 1. [Indoleamine precursors in depression (author's transl)].
    Coppen A; Wood K
    Encephale; 1979; 5(5 Suppl):627-32. PubMed ID: 95009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of serotonin in affective disorders (author's transl)].
    Lingjaerde O
    Encephale; 1979; 5(5 Suppl):499-506. PubMed ID: 95007
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical aspects of depression.
    Coppen AJ
    Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856
    [No Abstract]   [Full Text] [Related]  

  • 4. L-tryptophan in depression.
    Farkas T; Dunner DL; Fieve RR
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of indole amines in depression.
    Hullin RP
    Postgrad Med J; 1976; 52(3 suppl):18-24. PubMed ID: 785421
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors.
    Baldessarini RJ
    Psychopharmacol Bull; 1984; 20(2):224-39. PubMed ID: 6728992
    [No Abstract]   [Full Text] [Related]  

  • 7. The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
    Praag HM
    Biol Psychiatry; 1977 Feb; 12(1):101-31. PubMed ID: 300032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CSF levels of 5-HIAA in migraine during tryptophan therapy (author's transl)].
    Poloni M; Nappi G; Kauchtschischvili G; Savoldi F
    Riv Patol Nerv Ment; 1974 Oct; 95(5):620-3. PubMed ID: 4470262
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
    Celada P; Pérez J; Alvarez E; Artigas F
    J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of depression with serotonin precursors.
    van Praag HM
    Biol Psychiatry; 1981 Mar; 16(3):291-310. PubMed ID: 6164407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The indoleamine hypothesis of depression: an overview and pilot study.
    Zarcone VP; Berger PA; Brodie KH; Sack R; Barchas JD
    Dis Nerv Syst; 1977 Aug; 38(8):646-53. PubMed ID: 328245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central monoamine metabolism in depressions. I. Serotonin and related compounds.
    van Praag HM
    Compr Psychiatry; 1980; 21(1):30-43. PubMed ID: 6153593
    [No Abstract]   [Full Text] [Related]  

  • 14. Twenty-four hour rhythms in serum and brain indoleamine concentrations: tryptophan-5-hydroxylase and monoamine oxidase activity in the rat.
    Hillier JG; Redfern PH
    Int J Chronobiol; 1977; 4(3):197-210. PubMed ID: 301510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of tryptophan in combination with other antidepressant treatments: a review.
    Young SN
    J Psychiatry Neurosci; 1991 Dec; 16(5):241-6. PubMed ID: 1797098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan metabolism in the joint diseases.
    Igari T; Obara K; Ono S; Toba Y
    Acta Vitaminol Enzymol; 1975; 29(1-6):194-7. PubMed ID: 1244092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of neurotransmitter precursors for treatment of depression.
    Meyers S
    Altern Med Rev; 2000 Feb; 5(1):64-71. PubMed ID: 10696120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tryptophane and affective disorders (author's transl)].
    Cassano GB; Castrogiovanni P; Placidi GF; Conti L
    Riv Patol Nerv Ment; 1974 Aug; 95(4):222-36. PubMed ID: 4470244
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic properties of serotonergic agents and antidepressant drugs.
    Fuller RW
    J Clin Psychiatry; 1987 Mar; 48 Suppl():5-11. PubMed ID: 3493240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.